Kabayama et al. demonstrated when GM3 levels increase, it inhibits insulin signaling by binding to the insulin receptor (IR) and disrupting the interaction between caveolin-1 and the insulin receptor, thereby contributing to the development of insulin resistance [54]. The gene discussed is INS; the disease is Insulin resistance.